S&P 500   3,916.17 (-4.22%)
DOW   31,418.76 (-3.78%)
QQQ   291.53 (-4.78%)
AAPL   140.53 (-5.84%)
MSFT   254.39 (-4.66%)
FB   193.27 (-4.61%)
GOOGL   2,254.16 (-3.23%)
AMZN   2,131.65 (-7.62%)
TSLA   708.55 (-6.97%)
NVDA   169.66 (-6.66%)
BABA   87.53 (-4.85%)
NIO   15.81 (-4.93%)
AMD   96.44 (-5.88%)
CGC   5.63 (-4.41%)
MU   71.14 (-4.48%)
T   20.20 (-1.80%)
GE   75.29 (-1.45%)
F   12.81 (-5.32%)
DIS   104.70 (-3.63%)
AMC   12.85 (-0.39%)
PFE   50.34 (-1.95%)
PYPL   77.16 (-3.25%)
NFLX   177.73 (-6.73%)
S&P 500   3,916.17 (-4.22%)
DOW   31,418.76 (-3.78%)
QQQ   291.53 (-4.78%)
AAPL   140.53 (-5.84%)
MSFT   254.39 (-4.66%)
FB   193.27 (-4.61%)
GOOGL   2,254.16 (-3.23%)
AMZN   2,131.65 (-7.62%)
TSLA   708.55 (-6.97%)
NVDA   169.66 (-6.66%)
BABA   87.53 (-4.85%)
NIO   15.81 (-4.93%)
AMD   96.44 (-5.88%)
CGC   5.63 (-4.41%)
MU   71.14 (-4.48%)
T   20.20 (-1.80%)
GE   75.29 (-1.45%)
F   12.81 (-5.32%)
DIS   104.70 (-3.63%)
AMC   12.85 (-0.39%)
PFE   50.34 (-1.95%)
PYPL   77.16 (-3.25%)
NFLX   177.73 (-6.73%)
S&P 500   3,916.17 (-4.22%)
DOW   31,418.76 (-3.78%)
QQQ   291.53 (-4.78%)
AAPL   140.53 (-5.84%)
MSFT   254.39 (-4.66%)
FB   193.27 (-4.61%)
GOOGL   2,254.16 (-3.23%)
AMZN   2,131.65 (-7.62%)
TSLA   708.55 (-6.97%)
NVDA   169.66 (-6.66%)
BABA   87.53 (-4.85%)
NIO   15.81 (-4.93%)
AMD   96.44 (-5.88%)
CGC   5.63 (-4.41%)
MU   71.14 (-4.48%)
T   20.20 (-1.80%)
GE   75.29 (-1.45%)
F   12.81 (-5.32%)
DIS   104.70 (-3.63%)
AMC   12.85 (-0.39%)
PFE   50.34 (-1.95%)
PYPL   77.16 (-3.25%)
NFLX   177.73 (-6.73%)
S&P 500   3,916.17 (-4.22%)
DOW   31,418.76 (-3.78%)
QQQ   291.53 (-4.78%)
AAPL   140.53 (-5.84%)
MSFT   254.39 (-4.66%)
FB   193.27 (-4.61%)
GOOGL   2,254.16 (-3.23%)
AMZN   2,131.65 (-7.62%)
TSLA   708.55 (-6.97%)
NVDA   169.66 (-6.66%)
BABA   87.53 (-4.85%)
NIO   15.81 (-4.93%)
AMD   96.44 (-5.88%)
CGC   5.63 (-4.41%)
MU   71.14 (-4.48%)
T   20.20 (-1.80%)
GE   75.29 (-1.45%)
F   12.81 (-5.32%)
DIS   104.70 (-3.63%)
AMC   12.85 (-0.39%)
PFE   50.34 (-1.95%)
PYPL   77.16 (-3.25%)
NFLX   177.73 (-6.73%)
NASDAQ:OPNT

Opiant Pharmaceuticals Insider Trades

$15.09
+0.39 (+2.65%)
(As of 05/18/2022 03:00 PM ET)
Add
Compare
Today's Range
$14.92
$15.53
50-Day Range
$10.12
$26.18
52-Week Range
$7.34
$37.71
Volume
1,062 shs
Average Volume
193,947 shs
Market Capitalization
$76.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.65

Opiant Pharmaceuticals (NASDAQ:OPNT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
28.56%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$93.06 K
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$1.98 M

Insider Buying and Selling by Quarter

Get OPNT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Opiant Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Opiant Pharmaceuticals (NASDAQ:OPNT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/27/2022Phil SkolnickInsiderSell1,518$26.19$39,756.42  
1/27/2022Roger CrystalCEOSell1,995$26.15$52,169.25  
1/10/2022David D O'tooleCFOSell432$30.60$13,219.20  
1/10/2022Phil SkolnickInsiderSell385$30.49$11,738.65  
1/10/2022Roger CrystalCEOSell1,058$30.49$32,258.42  
9/21/2021Thomas T ThomasDirectorSell831$24.12$20,043.72  
9/14/2021David D O'tooleCFOBuy200$19.12$3,824.00  
9/13/2021Craig A. CollardDirectorBuy2,500$18.13$45,325.0016,077  
8/31/2021Matthew R RuthInsiderBuy2,000$17.34$34,680.0017,000  
8/25/2021Michael SinclairDirectorSell50,269$14.69$738,451.61  
8/23/2021Michael SinclairDirectorSell65,124$16.50$1,074,546.00209,194  
8/16/2021David D O'tooleCFOBuy600$15.38$9,228.0023,815  
3/17/2021Gabrielle Alison SilverDirectorSell13,006$11.31$147,097.86
9/3/2020Thomas T ThomasDirectorBuy2,500$8.40$21,000.004,500  
6/11/2020David D O'tooleCFOBuy1,000$8.64$8,640.00
5/26/2020David D O'tooleCFOBuy1,000$10.90$10,900.00
12/12/2019Ann L MacdougallDirectorBuy5,000$13.51$67,550.00
12/3/2019Phil SkolnickInsiderSell7,143$13.47$96,216.21
11/22/2019Gabrielle Alison SilverDirectorBuy1,785$13.19$23,544.15
11/15/2019David D O'tooleCFOBuy1,100$14.10$15,510.00
11/5/2019Phil SkolnickInsiderSell10,000$15.80$158,000.00
10/3/2019Phil SkolnickInsiderSell10,000$14.68$146,800.00
9/12/2019Michael SinclairDirectorSell60,000$12.52$751,200.00
9/4/2019Phil SkolnickInsiderSell10,000$14.15$141,500.0010,000  
8/15/2019David D O'tooleCFOBuy1,000$15.20$15,200.00  
8/13/2019David D O'tooleCFOBuy1,000$15.46$15,460.00  
8/2/2019Phil SkolnickInsiderSell10,000$11.60$116,000.00  
7/2/2019Phil SkolnickInsiderSell10,000$13.19$131,900.00  
6/4/2019Phil SkolnickInsiderSell10,000$11.71$117,100.00  
5/2/2019Phil SkolnickInsiderSell10,000$11.39$113,900.00  
4/8/2019Roger CrystalCEOSell28,773$12.03$346,139.19  
4/4/2019Roger CrystalCEOSell21,227$12.00$254,724.00  
4/2/2019Phil SkolnickInsiderSell10,000$12.66$126,600.00  
3/1/2019Phil SkolnickInsiderSell10,000$14.95$149,500.00  
2/4/2019Phil SkolnickInsiderSell10,000$15.32$153,200.00  
1/8/2019Roger CrystalCEOSell50,000$13.34$667,000.00  
1/4/2019Phil SkolnickInsiderSell10,000$13.76$137,600.00  
12/6/2018Phil SkolnickInsiderSell4,321$16.06$69,395.26  
11/5/2018Phil SkolnickInsiderSell1,821$18.01$32,796.21  
10/9/2018Roger CrystalCEOSell10,847$17.21$186,676.87  
10/4/2018Phil SkolnickInsiderSell4,778$18.32$87,532.96  
10/4/2018Roger CrystalCEOSell18,450$18.11$334,129.50  
8/14/2018David D O'tooleCFOBuy1,015$15.40$15,631.00  
6/4/2018Ann L MacdougallDirectorBuy5,000$16.51$82,550.00  
5/18/2018Thomas T ThomasDirectorSell2,763$16.44$45,423.72  
5/16/2018David D O'tooleCFOBuy2,000$16.95$33,900.00  
5/15/2018Thomas T ThomasDirectorSell4,300$18.35$78,905.00  
5/11/2018David D O'tooleCFOBuy3,000$18.85$56,550.00  
12/18/2017Geoffrey WolfMajor ShareholderSell34,938$22.67$792,044.46  
12/8/2017Geoffrey WolfMajor ShareholderSell2,570$30.40$78,128.00  
1/17/2017Michael SinclairInsiderBuy3,500$7.01$24,535.00132,720  
1/17/2017Roger CrystalCEOBuy3,475$6.99$24,290.258,475  
1/13/2017Kevin PollackInsiderBuy4,820$6.98$33,643.604,820  
(Data available from 1/1/2013 forward)












Opiant Pharmaceuticals (NASDAQ:OPNT) Insider Trade Frequently Asked Questions

Who is on Opiant Pharmaceuticals's Insider Roster?

The list of insiders at Opiant Pharmaceuticals includes Ann L Macdougall, Craig A. Collard, David D O'toole, Gabrielle Alison Silver, Matthew R Ruth, Michael Sinclair, Phil Skolnick, Roger Crystal, and Thomas T Thomas. Learn more on insiders at OPNT.

What percentage of Opiant Pharmaceuticals stock is owned by insiders?

28.56% of Opiant Pharmaceuticals stock is owned by insiders. Learn more on OPNT's insider holdings.

Which Opiant Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased Opiant Pharmaceuticals stock in the last 24 months: Craig A. Collard ($45,325.00), David D O'toole ($32,592.00), Matthew R Ruth ($34,680.00), and Thomas T Thomas ($21,000.00).

How much insider buying is happening at Opiant Pharmaceuticals?

Insiders have purchased a total of 9,800 Opiant Pharmaceuticals shares in the last 24 months for a total of $133,597.00 bought.

Which Opiant Pharmaceuticals insiders have been selling company stock?

The following insiders have sold Opiant Pharmaceuticals stock in the last 24 months: David D O'toole ($13,219.20), Gabrielle Alison Silver ($147,097.86), Michael Sinclair ($1,812,997.61), Phil Skolnick ($51,495.07), Roger Crystal ($84,427.67), and Thomas T Thomas ($20,043.72).

How much insider selling is happening at Opiant Pharmaceuticals?

Insiders have sold a total of 134,618 Opiant Pharmaceuticals shares in the last 24 months for a total of $2,129,281.13 sold.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.